TITLE

Tuberculin anergy

PUB. DATE
December 1970
SOURCE
British Medical Journal;12/5/1970, Vol. 4 Issue 5735, p573
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64098621

 

Related Articles

  • Anergy skin testing and preventative therapy for HIV-infeected persons: Revised...  // MMWR: Morbidity & Mortality Weekly Report;9/5/1997 Supplement RR-15, Vol. 46, p1 

    Looks at the use of anergy skin testing and purified protein derivative (PPD)-tuberculin skin testing of persons infected with human immunodeficiency virus (HIV). Factors which limit the usefulness of anergy skin testing; Role of anergy skin testing in tuberculosis prevention; Definition of...

  • Anergy Compromises Screening for Tuberculosis in High Risk Populations. Zoloth, Stephen R.; Safyer, Steven; Rosen, Judith; Michaels, David; Alcabes, Philip; Bellin, Eran; Braslow, Charles // American Journal of Public Health;May93, Vol. 83 Issue 5, p749 

    Anergy may occur in groups at high risk for tuberculosis, compromising tuberculin skin testing. Within New York City's correctional system, anergy prevalence was 25% among opiate users referred to detoxification programs and 3% in the general population. Correlates of anergy were recent weight...

  • Anergy Panels as Routine Adjunct to TB Skin Testing. Huffman, Grace Brooke // American Family Physician;10/1/2000, Vol. 62 Issue 7, p1631 

    Presents information on a review of the history and use of the anergy panel by B.S. Slovis and others. Description of the study and its results; Assertion that a lack of reactivity to an anergy panel does not aid in predicting the lack of occurrence or accuracy of tuberculin reactivity.

  • Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group. Markowitz, Norman; Hansen, Nellie I.; Wilcosky, Timothy C.; Hopewell, Philip C.; Glassroth, Jeffrey; Kvale, Paul A.; Mangura, Bonita T.; Osmond, Dennis; Wallace, Jeanne M.; Rosen, Mark J.; Reichman, Lee B.; Markowitz, N; Hansen, N I; Wilcosky, T C; Hopewell, P C; Glassroth, J; Kvale, P A; Mangura, B T; Osmond, D; Wallace, J M // Annals of Internal Medicine;8/1/93, Vol. 119 Issue 3, p185 

    Objective: To determine the prevalence and predictors of reactivity to tuberculin purified protein derivative (PPD) and skin test anergy in patients with human immunodeficiency virus (HIV) infection and in HIV-seronegative controls.Design: Cross-sectional analysis of...

  • A study of bacillus Calmette-Guérin vaccination and the Kveim reaction. Israel, Harold; Sones, Maurice; Israel, H; Sones, M // Annals of Internal Medicine;Jan66, Vol. 64 Issue 1, p87 

    Presents a study of Kveim reactivity after bacillus Calmette-Gu é rin vaccination of patients who had recovered from sarcoidosis. Relationship of the Kveim reaction and tuberculin anergy; Material and methods used in the study; Subjects recovered from sarcoidosis.

  • Sequestration of T Lymphocytes to Body Fluids in Tuberculosis: Reversal of Anergy following Chemotherapy. Dieli, Francesco; Friscia, Giuseppe; Di Sano, Caterina; Ivanyi, Juraj; Singh, Mahavir; Spallek, Ralph; Sireci, Guido; Titone, Lucina; Salerno, Alfredo // Journal of Infectious Diseases;7/1/99, Vol. 180 Issue 1, p225 

    Studies the specificity of CD4 T lymphocytes in six patients affected by tuberculosis who had negative tuberculin purified protein derivative (PPD) skin tests at diagnosis. Patients' response to PPD after chemotherapy; Compartmentalization of CD4 T cells; Occurrence of anergy in patients...

  • SKIN TEST ANERGY AMONG INJECTION DRUG USERS RECRUITED FROM COMMUNITY SETTINGS. Lifson, Alan R.; Thompson, Suzanne; Grant, Suzanne; Hilk, Rose; Lorviek, Jennifer // Journal of Drug Issues;Fall98, Vol. 28 Issue 4, p891 

    Five hundred ninety-two drug users (IDUs) from community settings in San Francisco and Oakland, California, were screened for tuberculosis using the tuberculin skin test, as well as for skin test anergy using two controls: mumps antigen and either tetanus toxoid or Candida. Those nonresponsive...

  • Outbreak of bovine tuberculosis featuring anergy to the skin test, udder lesions and milkborne disease in young calves. Houlihan, M. G.; Dixon, F. W.; Page, N. A. // Veterinary Record: Journal of the British Veterinary Association;9/20/2008, Vol. 163 Issue 12, p357 

    A severe outbreak of bovine tuberculosis in a 1300-head, multisite dairy herd in Great Britain had several unusual features, including anergy to the tuberculin skin test, milkborne disease in calves and a farm cat, and a risk of human infection. The outbreak was controlled by culling 221 cattle...

  • Prevalence of positive ppd in a cohort of rheumatoid arthritis patients. Tamborenea, Maria Natalia; Tate, Guillermo; Mysler, Eduardo; Debonis, Jose; Schijedman, Adrian // Rheumatology International;Mar2010, Vol. 30 Issue 5, p613 

    The main objective of this study is to determine the prevalence of positive and anergic tuberculin skin test (ppd) in a rheumatoid arthritis cohort of patients (RA) and assess the association among ppd results and clinical and treatment variables. Patients with RA diagnosis were included. The...

  • Tuberculin Skin Testing in Patients with HIV Infection: Limited Benefit of Reduced Cutoff Values. Cobelens, Frank G.; Egwaga, Saidi M.; van Ginkel, Tessa; Muwinge, Hemed; Matee, Mecky I.; Borgdorff, Martien W. // Clinical Infectious Diseases;9/1/2006, Vol. 43 Issue 5, p634 

    Background. When determining eligibility for isoniazid preventive therapy of human immunodeficiency virus (HIV)-infected patients, the cutoff value of the tuberculin skin test (TST) is often reduced from an induration of 10 mm in diameter to one of 5 mm in diameter to compensate for loss of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics